Shell Asset Management Co

SEC CIK: 0001211028
Latest filing: Nov 7, 2025

SEC filings (opens in a new tab)

DRNA holding history

Dicerna Pharmaceuticals Inc in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DRNA overview All 13F holders of DRNA Full Q3 2025 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of DRNA by Shell Asset Management Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−10,432−100.0%	Sold out	Holders
Q3 2021	10,432	$210.0K	<0.1%	−450−4.1%	Reduced	Holders
Q2 2021	10,882	$406.0K	<0.1%	+590+5.7%	Added	Holders
Q1 2021	10,292	$263.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.